EMMAUS MEDICAL
Emmaus Medical is a Torrance, California private pharmaceutical company developing and bringing to market new treatments for rare diseases and conditions. Emmaus Medical launched its first product, NutreStore [L-glutamine powder for an oral solution] for the treatment of Short Bowel Syndrome (SBS) in June 2008. The company is currently conducting a Phase 3 clinical trial to investigate the safety and efficacy of oral L-glutamine for the treatment of sickle cell disease. They are initially focusing our product development efforts on Sickle Cell Disease, a genetic disorder Emmaus Medical has received FDA orphan drug designation and fast track designation for its sickle cell treatment. The company was founded in 2000 and is headquartered in Torrance, California, United States.
EMMAUS MEDICAL
Industry:
Biopharma Biotechnology Health Care Life Science Pharmaceutical
Founded:
2000-01-01
Address:
Torrance, California, United States
Country:
United States
Website Url:
http://www.emmausmedical.com
Total Employee:
11+
Status:
Active
Contact:
(877)420-6493
Total Funding:
99.23 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt Google Universal Analytics Apache Amazon Google Apps For Business
Similar Organizations
Adial Pharmaceuticals
Adial Pharmaceuticals develops prescription medications for addiction and related disorders.
Agile Therapeutics
Agile Therapeutics is pharmaceutical company developing contraceptive healthcare products for women.
Apexigen
Apexigen is a clinical-stage biopharmaceutical company focused on discovering and developing a new antibody therapeutics for oncology.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
BioNTech
BioNTech is a biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Eikonoklastes Therapeutics
Eikonoklastes Therapeutics is a preclinical-stage biopharmaceutical company developing next-generation tissue factor (TF) immunotherapies.
Epizyme
Epizyme is a biopharmaceutical company focusing on treatments for blood cancer and tumors.
Fortress Biotech
Fortress Biotech is biopharmaceutical company focused on acquiring, developing, and commercializing drugs and drug candidates.
Neurana Pharmaceuticals
Neurana Pharmaceuticals is currently developing a novel treatment for acute muscle spasms.
Relypsa
Relypsa is a biopharmaceutical company developing drugs for treating cardiovascular and renal diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Trevena
Trevena is a clinical stage biopharmaceutical company discovering and developing G-protein coupled receptors (GPCR) biased ligands.
Urovant Sciences
Urovant Sciences is a global biopharmaceutical company focused on developing novel therapies for urologic conditions.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Board_member
Board_member
2011-08-01
Current Employees Featured
Charles Stark Senior Vice President of Research & Development @ Emmaus Medical
Senior Vice President of Research & Development
2013-11-01
Yasushi Nagasaki Senior Vice President of Finance @ Emmaus Medical
Senior Vice President of Finance
2011-01-01
Lan T. Tran Co-President, Chief Administrative Officer & Corporate Secretary @ Emmaus Medical
Co-President, Chief Administrative Officer & Corporate Secretary
2008-05-01
Yutaka Niihara Co-Founder, CEO & Chairman @ Emmaus Medical
Co-Founder, CEO & Chairman
2003-01-01
Henry A. McKinnell Chairman @ Emmaus Medical
Chairman
Willis C. Lee Chief Operating Officer @ Emmaus Medical
Chief Operating Officer
2011-04-01
Peter B Ludlum Management Consultant @ Emmaus Medical
Management Consultant
2017-06-01
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-07-23 | Mynd Analytics | Mynd Analytics acquired by Emmaus Medical | N/A |
Investors List
Lincoln Park Capital Fund
Lincoln Park Capital Fund investment in Post-IPO Equity - Emmaus Medical
Agility Capital
Agility Capital investment in Debt Financing - Emmaus Medical
Official Site Inspections
http://www.emmausmedical.com Semrush global rank: 5.03 M Semrush visits lastest month: 1.66 K
- Host name: 104.43.142.33
- IP address: 104.43.142.33
- Location: Des Moines United States
- Latitude: 41.6006
- Longitude: -93.6112
- Metro Code: 679
- Timezone: America/Chicago
- Postal: 50307
More informations about "Emmaus Medical"
Emmaus Medical - Crunchbase Company Profile
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.See details»
Mission - Emmaus Medical, Inc.
The mission of Emmaus Life Sciences is to improve the lives of people in need through the discovery, development and commercialization of innovative treatments and therapies. Our …See details»
Emmaus Medical - 2025 Company Profile - Tracxn
5 days ago Emmaus Medical - Small molecule therapeutics for the treatment of sickle cell anemia and sickle ß0-thalassemia. Acquired by Generex Biotechnology. Raised funding over …See details»
UNITED STATES - ir.emmausmedical.com
Delaware (State or other jurisdiction of incorporation or organization) 21250 Hawthorne Boulevard, Suite 800 Torrance, California 90503 (Address of principal executive offices) (Zip …See details»
10-Q - ir.emmausmedical.com
Sep 30, 2024 87-0419387 (State or other jurisdiction of incorporation or organization)See details»
Emmaus Life Sciences Provides Additional Operational and OTC …
Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company engaged in the discovery, development, marketing and sale of innovative treatments and therapies, including …See details»
Emmaus Life Sciences Reports Annual Financial Results for 2020 …
Dec 31, 2020 About Emmaus Life Sciences Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company engaged in the discovery, development, marketing and sale of …See details»
Emmaus Life Sciences - Company Information, Competitors, News …
Find useful insights on Emmaus Life Sciences's company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at Emmaus Life …See details»
10-K - ir.emmausmedical.com
Dec 31, 2023 Indicate by check mark if the registrant is a well‑known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐No☒See details»
Emmaus Life Sciences, Inc - LinkedIn
Emmaus Life Sciences, Inc | 6,051 followers on LinkedIn. Improving the lives of people with rare disease. | Emmaus Life Sciences, Inc. is a biopharmaceutical company engaged in the …See details»
Emmaus Life Sciences Reports Improved Quarterly Financial Results
Dec 31, 2023 Torrance CA, November 19, 2024 - Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle …See details»
Emmaus Life Sciences, a Leader in Sickle Cell Disease Treatment, to ...
Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company engaged in the discovery, development, marketing and sale of innovative treatments and therapies, including …See details»
Privacy Policy - Emmaus Medical, Inc.
Emmaus Life Sciences, Inc. takes all reasonable steps to protect the privacy of visitors to our web site (“Site”).See details»
Emmaus Life Sciences Inc (QB) Stock Price - EMMA | ADVFN
Emmaus Life Sciences (QB) (EMMA) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more.See details»
Sickle Cell Disease Association of America, Inc. Partners With …
BALTIMORE-- (BUSINESS WIRE)--The Sickle Cell Disease Association of America, Inc. (SCDAA) and Emmaus Life Sciences, Inc. have announced a new partnership involving …See details»
Emmaus Life Sciences Provides Update in Response to the …
Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company engaged in the discovery, development, marketing and sale of innovative treatments and therapies, including …See details»
EX-10.1 - ir.emmausmedical.com
Delivery of Purchased Amount: Seller must deposit all Future Receipts into the single business banking account specified above, which may not be used for any personal, family or …See details»
Emmaus Life Sciences, a Leader in Sickle Cell Disease Treatment, to ...
TORRANCE, Calif.-- Emmaus Life Sciences, Inc. (Emmaus) is a proud sponsor of the upcoming 12th Annual Sickle Cell Disease and Thalassaemia (ASCAT) Conference to be held in London …See details»